Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ANIK

ANIK News

Newswire

16:22

Anika Therapeutics Q3 Earnings Outperform Estimates, Shares Down 41.5% YTD

15:31

Anika Therapeutics: Barrington Research raises PT to $16, maintains Outperform rating.

20:37

Anika Therapeutics: Undervalued Biotech with Steady Loss Reductions and Moderate Growth Prospects

10:14

It looks like you sent an empty object `{}`. Could you clarify if there's a specific question or task you'd like assistance with? I'm here to help! .

07:17

Anika Therapeutics Reports Q3 Revenue Above Estimates, Maintains Guidance

View More

About ANIK

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More